SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

The pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with...

Full description

Bibliographic Details
Main Authors: Garcia-Reitböck, P, Anichtchik, O, Bellucci, A, Iovino, M, Ballini, C, Fineberg, E, Ghetti, B, Della Corte, L, Spano, P, Tofaris, G, Goedert, M, Spillantini, MG
Format: Journal article
Language:English
Published: 2010
_version_ 1797095027902513152
author Garcia-Reitböck, P
Anichtchik, O
Bellucci, A
Iovino, M
Ballini, C
Fineberg, E
Ghetti, B
Della Corte, L
Spano, P
Tofaris, G
Goedert, M
Spillantini, MG
author_facet Garcia-Reitböck, P
Anichtchik, O
Bellucci, A
Iovino, M
Ballini, C
Fineberg, E
Ghetti, B
Della Corte, L
Spano, P
Tofaris, G
Goedert, M
Spillantini, MG
author_sort Garcia-Reitböck, P
collection OXFORD
description The pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with Lewy bodies. We previously described a transgenic mouse line expressing truncated human α-synuclein(1-120) that develops α-synuclein aggregates, striatal dopamine deficiency and reduced locomotion, similar to Parkinson's disease. We now show that in the striatum of these mice, as in Parkinson's disease, synaptic accumulation of α-synuclein is accompanied by an age-dependent redistribution of the synaptic SNARE proteins SNAP-25, syntaxin-1 and synaptobrevin-2, as well as by an age-dependent reduction in dopamine release. Furthermore, the release of FM1-43 dye from PC12 cells expressing either human full-length α-synuclein(1-140) or truncated α-synuclein(1-120) was reduced. These findings reveal a novel gain of toxic function of α-synuclein at the synapse, which may be an early event in the pathogenesis of Parkinson's disease. © 2010 The Author(s).
first_indexed 2024-03-07T04:22:10Z
format Journal article
id oxford-uuid:cb62ffa0-c8bf-4733-9a5a-13a5ede8b6f9
institution University of Oxford
language English
last_indexed 2024-03-07T04:22:10Z
publishDate 2010
record_format dspace
spelling oxford-uuid:cb62ffa0-c8bf-4733-9a5a-13a5ede8b6f92022-03-27T07:14:28ZSNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cb62ffa0-c8bf-4733-9a5a-13a5ede8b6f9EnglishSymplectic Elements at Oxford2010Garcia-Reitböck, PAnichtchik, OBellucci, AIovino, MBallini, CFineberg, EGhetti, BDella Corte, LSpano, PTofaris, GGoedert, MSpillantini, MGThe pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with Lewy bodies. We previously described a transgenic mouse line expressing truncated human α-synuclein(1-120) that develops α-synuclein aggregates, striatal dopamine deficiency and reduced locomotion, similar to Parkinson's disease. We now show that in the striatum of these mice, as in Parkinson's disease, synaptic accumulation of α-synuclein is accompanied by an age-dependent redistribution of the synaptic SNARE proteins SNAP-25, syntaxin-1 and synaptobrevin-2, as well as by an age-dependent reduction in dopamine release. Furthermore, the release of FM1-43 dye from PC12 cells expressing either human full-length α-synuclein(1-140) or truncated α-synuclein(1-120) was reduced. These findings reveal a novel gain of toxic function of α-synuclein at the synapse, which may be an early event in the pathogenesis of Parkinson's disease. © 2010 The Author(s).
spellingShingle Garcia-Reitböck, P
Anichtchik, O
Bellucci, A
Iovino, M
Ballini, C
Fineberg, E
Ghetti, B
Della Corte, L
Spano, P
Tofaris, G
Goedert, M
Spillantini, MG
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
title SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
title_full SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
title_fullStr SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
title_full_unstemmed SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
title_short SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
title_sort snare protein redistribution and synaptic failure in a transgenic mouse model of parkinson s disease
work_keys_str_mv AT garciareitbockp snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT anichtchiko snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT belluccia snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT iovinom snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT ballinic snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT fineberge snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT ghettib snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT dellacortel snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT spanop snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT tofarisg snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT goedertm snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease
AT spillantinimg snareproteinredistributionandsynapticfailureinatransgenicmousemodelofparkinsonsdisease